Circulation· 2019Q1
Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association
- 496citations
- Q1SCImago
- 2019year
Short summary
Two US FDA-cleared pharmacomechanical devices are now available for acute intermediate- and high-risk pulmonary embolism (PE), with more in development, prompting a need for evidence-based guidelines on their use.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine